TIARA DAVISON: Open Payments
NPI 1720720071 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 14 payments from 9 companies in 2025. Trend: 2023 $469 · 2024 $441 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $125 |
| Astellas Pharma US Inc | 3 | $57 |
| Acella Pharmaceuticals, LLC | 2 | $38 |
| Exact Sciences Corporation | 2 | $34 |
| Corcept Therapeutics | 2 | $32 |
| IBSA Pharma Inc. | 1 | $22 |
| Amgen Inc. | 1 | $18 |
| SI-BONE, INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
Products named: Ozempic, Veozah, NP Thyroid 60, Korlym, Tirosint, The Cologuard Plus Collection Kit, OTEZLA, KISUNLA.
Industry payments across TX — which companies pay providers there.
